GB202203588D0 - Cancer diagnostic - Google Patents

Cancer diagnostic

Info

Publication number
GB202203588D0
GB202203588D0 GBGB2203588.5A GB202203588A GB202203588D0 GB 202203588 D0 GB202203588 D0 GB 202203588D0 GB 202203588 A GB202203588 A GB 202203588A GB 202203588 D0 GB202203588 D0 GB 202203588D0
Authority
GB
United Kingdom
Prior art keywords
cancer diagnostic
diagnostic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2203588.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argonaut Therapeutics Ltd
Original Assignee
Argonaut Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argonaut Therapeutics Ltd filed Critical Argonaut Therapeutics Ltd
Priority to GBGB2203588.5A priority Critical patent/GB202203588D0/en
Publication of GB202203588D0 publication Critical patent/GB202203588D0/en
Priority to PCT/GB2023/050601 priority patent/WO2023175319A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2203588.5A 2022-03-15 2022-03-15 Cancer diagnostic Ceased GB202203588D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2203588.5A GB202203588D0 (en) 2022-03-15 2022-03-15 Cancer diagnostic
PCT/GB2023/050601 WO2023175319A1 (fr) 2022-03-15 2023-03-14 Diagnostic et traitement du cancer au moyen d'un inhibiteur de prmt5

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2203588.5A GB202203588D0 (en) 2022-03-15 2022-03-15 Cancer diagnostic

Publications (1)

Publication Number Publication Date
GB202203588D0 true GB202203588D0 (en) 2022-04-27

Family

ID=81254800

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2203588.5A Ceased GB202203588D0 (en) 2022-03-15 2022-03-15 Cancer diagnostic

Country Status (2)

Country Link
GB (1) GB202203588D0 (fr)
WO (1) WO2023175319A1 (fr)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US626550A (en) 1899-06-06 Valve
CA1178414A (fr) 1978-02-08 1984-11-27 Toyo Boseki Kabushiki Kaisha (Trading Under The Name Of Toyobo Co., Ltd.) Materiau d'emballage etanche
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
JP6678455B2 (ja) 2012-12-21 2020-04-08 エピザイム，インコーポレイティド Ｐｒｍｔ５阻害剤およびその使用
CA2942833A1 (fr) * 2013-03-15 2014-09-18 Ohio State Innovation Foundation Inhibiteurs de prmt5 et leurs procedes d'utilisation
AR104326A1 (es) 2015-05-04 2017-07-12 Lilly Co Eli Compuestos nucleósidos 5-sustituidos
TWI791251B (zh) 2015-08-26 2023-02-01 比利時商健生藥品公司 使用作為ｐｒｍｔ５抑制劑之新穎經６-６雙環芳香環取代之核苷類似物
GB201704325D0 (en) 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
GB201704327D0 (en) 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
GB201905780D0 (en) * 2019-04-25 2019-06-05 La Thangue Nicholas Cancer therapy

Also Published As

Publication number Publication date
WO2023175319A1 (fr) 2023-09-21

Similar Documents

Publication Publication Date Title
IL284963A (en) Diagnostic imaging materials for cancer
GB201903546D0 (en) Cancer treatment
EP4127245A4 (fr) Diagnostic pour le cancer buccal
GB201908591D0 (en) Methods for cancer diagnosis
GB201905780D0 (en) Cancer therapy
GB202301902D0 (en) Combination therapy for cancer
GB202203588D0 (en) Cancer diagnostic
GB202012326D0 (en) Diagnostic
GB201917428D0 (en) Prostate cancer diagnostic
IL281556A (en) Diagnostic methods for triple-negative breast cancer
GB202017340D0 (en) Lung cancer diagnostic
GB202307101D0 (en) Diagnostic cancer signatures
GB202201300D0 (en) Diagnostic
GB202103200D0 (en) Lung Cancer diagnosis
GB202011743D0 (en) Diagnosis of cancer
GB202000739D0 (en) Cancer
GB202316758D0 (en) Diagnostic methods
GB202312237D0 (en) Diagnosis
GB202201726D0 (en) Diagnosis
GB202303784D0 (en) Cancer treatment
GB202217305D0 (en) Cancer treatment
GB202211123D0 (en) Cancer treatment
GB202210038D0 (en) Cancer treatment
GB202206948D0 (en) Cancer treatment
GB202318158D0 (en) Cancer therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)